Table 4. Mutation carriers stratified by brain amyloid load.
Exercise* | Family Mutation | EYO | Age** | EYO*Exercise | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Low exercise Mean (SE) Ɨ | High exercise Mean (SE) Ɨ | F | p | ηp2 | F | p | ηp2 | F | p | ηp2 | F | p | ηp2 | F | p | ηp2 | ||
PiB SUVR | MC PiB − (n = 68) | 1.09 (0.03) | 1.11 (0.02) | 1.16 | 0.28 | 0.019 | 0.30 | 0.74 | 0.010 | 2.27 | 0.14 | 0.036 | 0.97 | 0.33 | 0.016 | 0.48 | 0.49 | 0.008 |
MC PiB + (n = 71) | 2.36 (0.19) | 2.16 (0.15) | 8.20 | 0.006a | 0.114 | 0.51 | 0.60 | 0.016 | 16.22 | <0.001 | 0.202 | 1.92 | 0.17 | 0.029 | 7.04 | 0.01a | 0.099 | |
CSF Aβ42 (ng/L) | MC PiB − (n = 57) | 387.0 (47.3) | 427.8 (31.3) | 0.15 | 0.70 | 0.003 | 3.02 | 0.06 | 0.108 | 1.27 | 0.26 | 0.025 | 0.47 | 0.50 | 0.009 | 0.00 | 0.99 | 0.001 |
MC PiB + (n = 63) | 269.0 (34.9) | 290.3 (30.4) | 0.34 | 0.56 | 0.006 | 0.06 | 0.94 | 0.002 | 7.36 | 0.01 | 0.116 | 0.38 | 0.54 | 0.007 | 0.02 | 0.88 | 0.001 | |
CSF tau (ng/L) | MC PiB − (n = 57) | 57.5 (8.6) | 64.1 (5.7) | 0.01 | 0.98 | 0.001 | 0.30 | 0.74 | 0.012 | 1.03 | 0.31 | 0.020 | 0.15 | 0.70 | 0.003 | 0.16 | 0.69 | 0.003 |
MC PiB + (n = 64) | 109.9 (16.1) | 94.3 (13.4) | 0.51 | 0.48 | 0.009 | 1.16 | 0.32 | 0.039 | 2.22 | 0.14 | 0.037 | 1.16 | 0.29 | 0.020 | 3.16 | 0.08 | 0.052 |
Low exercisers reported less than 150 minutes per week of exercise, high exercisers reported 150 or more minutes of exercise per week.
The age variable was residualized from EYO.
Adjusted marginal means (standard error).
p-value remained significant (p < 0.05) after false discovery rate correction.
Abbreviations: CSF, cerebrospinal fluid; EYO, estimated years from expected symptom onset; MC, mutation carriers; ng/L, nanograms per litre; PiB SUVR, Pittsburgh Compound B standardised uptake value ratio; PiB -, PiB negative with an SUVR of less than 1·3; PiB +, PiB positive with an SUVR of 1·3 or higher SE, standard error.